The following information is missing from the Funding section: This work was supported by the National Institute of Allergy and Infectious Diseases (grant no. HHSN272200800056C to BC).
Reference
- 1.Callendret B, Vellinga J, Wunderlich K, Rodriguez A, Steigerwald R, Dirmeier U, et al. (2018) A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. PLoS ONE 13(2): e0192312 https://doi.org/10.1371/journal.pone.0192312 [DOI] [PMC free article] [PubMed] [Google Scholar]